Wall Street Zen Downgrades Relmada Therapeutics (NASDAQ:RLMD) to Strong Sell
Relmada Therapeutics (NASDAQ:RLMD – Get Free Report) was downgraded by research analysts at Wall Street Zen to a “strong sell” rating in a research note issued on Saturday. Relmada Therapeutics Price Performance RLMD stock opened at $0.64 on Friday. The stock has a market cap of $21.22 million, a price-to-earnings ratio of -0.22 and a […]
Relmada Therapeutics (NASDAQ:RLMD – Get Free Report) was downgraded by research analysts at Wall Street Zen to a “strong sell” rating in a research note issued on Saturday. Relmada Therapeutics Price Performance RLMD stock opened at $0.64 on Friday. The stock has a market cap of $21.22 million, a price-to-earnings ratio of -0.22 and a […]
